Genes for exceptional longevity

Annual Review of Gerontology and Geriatrics

Volumn 34, Issue 1, 2014, Pages 171-188

  Barzilai, Nir ^a   Atzmon, Gil ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN C3; BIOLOGICAL FACTOR; CHOLESTEROL ESTER TRANSFER PROTEIN; GROWTH HORMONE; INSULIN RECEPTOR; LIOTHYRONINE; LIPOPROTEIN; MICRORNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; SOMATOMEDIN C; THYROTROPIN; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR FKHRL1;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONCEPTUAL FRAMEWORK; DIABETES MELLITUS; DISEASE PREDISPOSITION; EPIGENETICS; EXCEPTIONAL LONGEVITY; EXERCISE; FAMILY; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENOTYPE; GROWTH HORMONE DEFICIENCY; HEART INFARCTION; HEREDITY; HORMONE RELEASE; HUMAN; HYPERTENSION; INHERITANCE; INSULIN SENSITIVITY; LARON SYNDROME; LIFESPAN; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; METHYLATION; MORTALITY; NEXT GENERATION SEQUENCING; OBESITY; PHENOTYPE; PREMATURE AGING; PROGENY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRANSIENT ISCHEMIC ATTACK;

EID: 84922986824     PISSN: 01988794     EISSN: 19444036     Source Type: Book Series    
DOI: 10.1891/0198-8794.34.171     Document Type: Chapter

References (59)

1. Accili, D. (1995). Molecular defects of the insulin receptor gene. Diabetes/Metabolism Research and Reviews, 11, 47-62.
2. Adams, E. R., Nolan, V. G., Andersen, S. L., Perls, T. T., & Terry, D. F. (2008). Centenarian offspring: Start healthier and stay healthier. Journal of the American Geriatrics Society, 56, 2089-2092. http://dx.doi.org/10.1111/j.1532-5415.2008.01949.x.
3. Andersen, S. L., Sebastiani, P., Dworkis, D. A., Feldman, L., & Perls, T. T. (2012). Health span approximates life span among many supercentenarians: Compression of morbidity at the approximate limit of life span. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67, 395-405. http://dx.doi.org/10.1093/gerona/glr223.
4. Arai, Y., & Hirose, N. (2004). Aging and HDL metabolism in elderly people more than 100 years old. Journal of Atherosclerosis and Thrombosis, 11, 246-252.
5. Atzmon, G., Barzilai, N., Hollowell, J. G., Surks, M. I., & Gabriely, I. (2009). Extreme longevity is associated with increased serum thyrotropin. The Journal of Clinical Endocrinology & Metabolism, 94, 1251-1254.
6. Atzmon, G., Cho, M., Cawthon, R. M., Budagov, T., Katz, M., Yang, X., Suh, Y. (2010). Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proceedings of the National Academy of Sciences of the United States of America, 107 (Suppl. 1), 1710-1717.
7. Atzmon, G., Pollin, T. I., Crandall, J., Tanner, K., Schechter, C. B., Scherer, P. E., Barzilai, N. (2008). Adiponectin levels and genotype: A potential regulator of life span in humans. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 63, 447-453.
8. Atzmon, G., Rincon, M., Rabizadeh, P., & Barzilai, N. (2005). Biological evidence for inheritance of exceptional longevity. Mechanisms of Ageing and Development, 126, 341-345.
9. Atzmon, G., Rincon, M., Schechter, C. B., Shuldiner, A. R., Lipton, R. B., Bergman, A., & Barzilai, N. (2006). Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biology, 4, e113.
10. Atzmon, G., Schechter, C., Greiner, W., Davidson, D., Rennert, G., & Barzilai, N. (2004). Clinical phenotype of families with longevity. Journal of the American Geriatrics Society, 52, 274-277.
11. Barzilai, N., Atzmon, G., Derby, C. A., Bauman, J. M., & Lipton, R. B. (2006). A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology, 67, 2170-2175.
12. Barzilai, N., Atzmon, G., Schechter, C., Schaefer, E. J., Cupples, A. L., Lipton, R., Shuldiner, A. R. (2003). Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA: The Journal of the American Medical Association, 290, 2030-2040. http://dx.doi.org/10.1001/jama.290.15.2030.
13. Barzilai, N., Guarente, L., Kirkwood, T. B., Partridge, L., Rando, T. A., & Slagboom, P. E. (2012). The place of genetics in ageing research. Nature Reviews Genetics, 13, 589-594. http://dx.doi.org/10.1038/nrg3290.
14. Beekman, M., Nederstigt, C., Suchiman, H. E., Kremer, D., van der Breggen, R., Lakenberg, N., Slagboom, P. E. (2010). Genome-wide association study (GWAS)-identifi ed disease risk alleles do not compromise human longevity. Proceedings of the National Academy of Sciences of the United States of America, 107, 18046-18049. http:// dx.doi.org/10.1073/pnas.1003540107.
15. Bergman, A., Atzmon, G., Ye, K., MacCarthy, T., & Barzilai, N. (2007). Buffering mechanisms in aging: A systems approach toward uncovering the genetic component of aging. PLOS Computational Biology, 3, e170. http://dx.doi.org/10.1371/journal.pcbi.0030170.
16. Bluher, M., Kahn, B. B., & Kahn, C. R. (2003). Extended longevity in mice lacking the insulin receptor in adipose tissue. Science, 299, 572-574. http://dx.doi.org/10.1126/science.1078223.
17. Bonafe, M., Barbieri, M., Marchegiani, F., Olivieri, F., Ragno, E., Giampieri, C., Paolisso, G. (2003). Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: Cues for an evolutionarily conserved mechanism of life span control. The Journal of Clinical Endocrinology & Metabolism, 88, 3299-3304.
18. Browner, W. S., Kahn, A. J., Ziv, E., Reiner, A. P., Oshima, J., Cawthon, R. M., Cummings, S. R. (2004). The genetics of human longevity. Am J Med, 117, 851-860. http:// dx.doi.org/10.1016/j.amjmed.2004.06.033.
19. Carter, C. S., Ramsey, M. M., Ingram, R. L., Cashion, A. B., Cefalu, W. T., Wang, Z. Q., & Sonntag, W. E. (2002). Models of growth hormone and IGF-I defi ciency: Applications to studies of aging processes and life-span determination. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 57, B177-B188.
20. Cellini, E., Nacmias, B., Olivieri, F., Ortenzi, L., Tedde, A., Bagnoli, S., Sorbi, S. (2005). Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. Mechanisms of Ageing and Development, 126, 826-828.
21. Corpas, E., Harman, S. M., & Blackman, M. R. (1993). Human growth hormone and human aging. Endocrine Reviews, 14, 20-39.
22. Corsonello, A., Montesanto, A., Berardelli, M., De Rango, F., Dato, S., Mari, V., Passarino, G. (2010). A cross-section analysis of FT3 age-related changes in a group of old and oldest-old subjects, including centenarians' relatives, shows that a down-regulated thyroid function has a familial component and is related to longevity. Age Ageing, 39, 723-727.
23. Cournil, A., & Kirkwood, T. B. (2001). If you would live long, choose your parents well. Trends in Genetics, 17, 233-235.
24. Curb, J. D., Abbott, R. D., Rodriguez, B. L., Masaki, K., Chen, R., Sharp, D. S., and Tall, A. R. (2004). A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. The Journal of Lipid Research, 45, 948-953.
25. Elahi, D., Muller, D. C., Tzankoff, S. P., Andres, R., & Tobin, J. D. (1982). Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man. The Journals of Gerontology, 37, 385-391.
26. Evert, J., Lawler, E., Bogan, H., & Perls, T. (2003). Morbidity profi les of centenarians: Survivors, delayers, and escapers. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 58, 232-237.
27. Florez, H., Ma, Y., Crandall, J. P., Perreault, L., Marcovina, S. M., Bray, G. A., Knowler, W. C. (2011). Parental longevity and diabetes risk in the Diabetes Prevention Program. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 66, 1211-1217. http://dx.doi.org/10.1093/gerona/glr114.
28. Fontbonne, A. M., & Eschwege, E. M. (1991). Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care, 14, 461-469.
29. Gombar, S., Jung, H. J., Dong, F., Calder, B., Atzmon, G., Barzilai, N., Suh, Y. (2012). Comprehensive microRNA profi ling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics, 13, 353. http://dx.doi.org/10.1186/1471-2164-13-353.
30. Goodman-Gruen, D., Barrett-Connor, E., & Rosen, C. (2000). IGF-I and ischemic heart disease in older people. Journal of the American Geriatrics Society, 48, 860-861.
31. Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., Wei, M., Madia, F., Cheng, C. W., Longo, V. D. (2011). Growth hormone receptor defi ciency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Science Translational Medicine, 3, 70ra13. http://dx.doi.org/10.1126/scitranslmed.3001845.
32. Han, J., Ryu, S., Moskowitz, D. M., Rothenberg, D., Leahy, D. J., Atzmon, G., Suh, Y. (2013). Discovery of novel non-synonymous SNP variants in 988 candidate genes from 6 centenarians by target capture and next-generation sequencing. Mechanisms of Ageing and Development. Advance online publication. http://dx.doi.org/10.1016/j.mad.2013.01.005.
33. Herskind, A. M., McGue, M., Holm, N. V., Sorensen, T. I., Harvald, B., & Vaupel, J. W. (1996). The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870-1900. Human Genetics, 97, 319-323.
34. Hippisley-Cox, J., Coupland, C., Pringle, M., Crown, N., & Hammersley, V. (2002). Married couples' risk of same disease: Cross sectional study. British Medical Journal, 325, 636.
35. Huffman, D. M., Deelen, J., Ye, K., Bergman, A., Slagboom, E. P., Barzilai, N., & Atzmon, G. (2012). Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: The case of the MTP gene. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67, 1153-1160. http:// dx.doi.org/10.1093/gerona/gls103.
36. Janssen, J. A., Stolk, R. P., Pols, H. A., Grobbee, D. E., & Lamberts, S. W. (1998). Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: Relation to cardiovascular risk factors and disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 277-282.
37. Juul, A. (1999). Determination of insulin-like growth factor-I in the monitoring of growth hormone treatment with respect to effi cacy of treatment and side effects: Should potential risks of cardiovascular disease and cancer be considered? Hormone Research, 51 (Suppl. 3), 141-148. http://dx.doi.org/53177.
38. Khan, A. S., Sane, D. C., Wannenburg, T., & Sonntag, W. E. (2002). Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovascular Research, 54, 25-35.
39. Laron, Z. (1999). The essential role of IGF-I: Lessons from the long-term study and treatment of children and adults with Laron syndrome. The Journal of Clinical Endocrinology & Metabolism, 84, 4397-4404.
40. Lipton, R. B., Hirsch, J., Katz, M. J., Wang, C., Sanders, A. E., Verghese, J., Derby, C.A. (2010). Exceptional parental longevity associated with lower risk of Alzheimer's disease and memory decline. Journal of the American Geriatrics Society, 58, 1043-1049. http://dx.doi.org/10.1111/j.1532-5415.2010.02868.x.
41. Lucchi, T., Arosio, B., Caloni, M., Ceconi, I., Calabresi, C., Scurati, S., & Vergani, C. (2005). [I405V polymorphism of the cholesteryl ester transfer protein gene in young and very old individuals]. Annali Italiani di Medicina Interna, 20, 45-50.
42. Marcus, R., Butterfield, G., Holloway, L., Gilliland, L., Baylink, D. J., Hintz, R. L., & Sherman, B. M. (1990). Effects of short term administration of recombinant human growth hormone to elderly people. The Journal of Clinical Endocrinology & Metabolism, 70, 519-527.
43. McGue, M., Vaupel, J. W., Holm, N., & Harvald, B. (1993). Longevity is moderately heritable in a sample of Danish twins born 1870-1880. The Journals of Gerontology, 48, B237-B244.
44. Mor, V. (2005). The compression of morbidity hypothesis: A review of research and prospects for the future. Journal of the American Geriatrics Society, 53, S308-S309. http://dx.doi.org/10.1111/j.1532-5415.2005.53496.x.
45. Orme, S. M., McNally, R. J., Cartwright, R. A., & Belchetz, P. E. (1998). Mortality and cancer incidence in acromegaly: A retrospective cohort study. United Kingdom Acromegaly Study Group. The Journal of Clinical Endocrinology & Metabolism, 83, 2730-2734.
46. Perls, T., Kunkel, L., & Puca, A. (2002). The genetics of aging. Current Opinion in Genetics & Development, 12, 362-369.
47. Perls, T., & Puca, A. (2002). The genetics of aging-Implications for pharmacogenomics. Pharmacogenomics, 3, 469-484.
48. Perls, T. T., Wilmoth, J., Levenson, R., Drinkwater, M., Cohen, M., Bogan, H., Puca, A. (2002). Life-long sustained mortality advantage of siblings of centenarians. Proceedings of the National Academy of Sciences of the United States of America, 99, 8442-8447.
49. Pollin, T. I., Damcott, C. M., Shen, H., Ott, S. H., Shelton, J., Horenstein, R. B., Shuldiner, A. R. (2008). A null mutation in human APOC3 confers a favorable plasma lipid profi le and apparent cardioprotection. Science, 322, 1702-1705. http://dx.doi.org/10.1126/science.1161524.
50. Rajpathak, S. N., Liu, Y., Ben-David, O., Reddy, S., Atzmon, G., Crandall, J., & Barzilai, N. (2011). Lifestyle factors of people with exceptional longevity. Journal of the American Geriatrics Society, 59, 1509-1512. http://dx.doi.org/10.1111 /j.1532-5415.2011.03498.x.
51. Rozing, M. P., Houwing-Duistermaat, J. J., Slagboom, P. E., Beekman, M., Frolich, M., de Craen, A. J., van Heemst, D. (2010). Familial longevity is associated with decreased thyroid function. The Journal of Clinical Endocrinology & Metabolism, 95, 4979-4984.
52. Rudman, D., Kutner, M. H., Rogers, C. M., Lubin, M. F., Fleming, G. A., & Bain, R. P. (1981). Impaired growth hormone secretion in the adult population: Relation to age and adiposity. Journal of Clinical Investigation, 67, 1361-1369.
53. Sanders, A. E., Wang, C., Katz, M., Derby, C. A., Barzilai, N., Ozelius, L., & Lipton, R. B. (2010). Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. JAMA: The Journal of the American Medical Association, 303, 150-158. http://dx.doi.org/10.1001/jama.2009.1988.
54. Serna, E., Gambini, J., Borras, C., Abdelaziz, K. M., Belenguer, A., Sanchis, P., Vina, J. (2012). Centenarians, but not octogenarians, up-regulate the expression of microRNAs. Scientifi c Reports, 2, 961. http://dx.doi.org/10.1038/srep00961.
55. Suh, Y., Atzmon, G., Cho, M. O., Hwang, D., Liu, B., Leahy, D. J., Cohen, P. (2008). Functionally signifi cant insulin-like growth factor I receptor mutations in centenarians. Proceedings of the National Academy of Sciences of the United States of America, 105, 3438-3442. http://dx.doi.org/10.1073/pnas.0705467105.
56. Tazearslan, C., Huang, J., Barzilai, N., & Suh, Y. (2011). Impaired IGF-IR signaling in cells expressing longevity-associated human IGF-IR alleles. Aging Cell, 10, 551-554. http://dx.doi.org/10.1111/j.1474-9726.2011.00697.x.
57. Vance, M. L., & Mauras, N. (1999). Growth hormone therapy in adults and children. The New England Journal of Medicine, 341, 1206-1216. http://dx.doi.org/10.1056 /NEJM199910143411607.
58. Volkova, M., Garg, R., Dick, S., & Boheler, K. R. (2005). Aging-associated changes in cardiac gene expression. Cardiovascular Research, 66, 194-204. http://dx.doi.org/10.1016/j.cardiores.2004.11.016.
59. Yashin, A. I., De Benedictis, G., Vaupel, J. W., Tan, Q., Andreev, K. F., Iachine, I. A., ... Franceschi, C. (2000). Genes and longevity: Lessons from studies of centenarians. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 55, B319-B328.